What You Should Know:
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionise healthcare and improve the human condition using molecular science…
Continue Reading
QuantHealth co-founders Arnon Horev and Orr (Ruti Benziman)
What You Should Know:
– In a decisive move towards faster and more efficient drug development, QuantHealth, a leading AI-powered clinical trial design company, has secured a strategic…
Continue Reading
Britton Burton Sr. Director of TPRM Strategy
Morgan Hague, Manager of IT Risk Management at Meditology Services
Leaps in healthcare technology continue to benefit humankind: from the advent of the X-ray in the 19th century to…
Continue Reading
Dx&Vx to leverage LG CNS’s AI in developing big data platformSouth Korean genetic analysis provider Dx&Vx has tapped LG CNS to co-develop a big healthcare data platform. The partnership, which is a first in…
Continue Reading
What You Should Know:
– Absci, a generative AI drug creation company, and PrecisionLife, a pioneer in computational biology for complex chronic diseases, have announced a powerful partnership to develop a joint portfolio of potential…
Continue Reading
AI revolutionizes healthcare through precise medical imaging, AI-assisted surgeries, accelerated research, drug development, and early disease detection. Remote patient care, fraud prevention, accurate cancer diagnosis, and gene editing are redefining healthcare standards. Collaboration between…
Continue Reading
Lance Hill, CEO of Within3
The cancer market for the pharma industry accounts for about a third of their product pipeline. With oncology drug sales set to top $390 billion by 2027, life science companies…
Continue Reading
What You Should Know:
– QuantHealth, an AI-powered clinical trial design startup, today announced a major product upgrade to its platform with the launch of Katina, a new tool that utilizes AI to simulate clinical…
Continue Reading
What You Should Know:
– Boehringer Ingelheim and IBM announced a collaboration to leverage IBM’s foundation model technologies for the discovery of novel candidate antibodies in drug development.
– The partnership will focus on utilizing IBM’s…
Continue Reading
Sabrina Steffen, Head of Data Strategy and Innovation for Data Management at IQVIA
In drug development, there is a critical focus on protocol design, because it is a key component to running a successful clinical…
Continue Reading
